| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $666.8M | +23.1% |
| Cost of Revenue | $199.3M | +42.1% |
| R&D Expense | $84.8M | +52.7% |
| SG&A Expense | $254.5M | +27.7% |
| Operating Income | $60.0M | -33.3% |
| Interest Expense | $40.0M | +25.9% |
| Pre-tax Income | $13.3M | -76.4% |
| Income Tax | -$2.6M | -118.1% |
| Net Income | $15.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $104.1M | -82.2% |
| Short-term Investments | $184.5M | +160.5% |
| Accounts Receivable | $98.4M | +2.2% |
| Inventory | $96.1M | -2.5% |
| Current Assets | $498.3M | -42.5% |
| Total Assets | $1.68B | -19.0% |
| Current Liabilities | $147.8M | -71.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $145.3M | +15.6% |
| Capital Expenditures | $30.1M | -34.4% |
| Investing Cash Flow | -$225.2M | -983.1% |
| Financing Cash Flow | -$401.5M | -205.5% |
| Free Cash Flow | $115.2M | +44.3% |
| -62.1% |
| EPS (Basic) | $0.35 | -63.2% |
| EPS (Diluted) | $0.34 | -63.0% |
| Total Liabilities |
| $906.2M |
| -32.6% |
| Stockholders' Equity | $775.0M | +6.1% |